Join
Live feed
·
INSIDERFilingvia Quantisnow
Kiniksa Pharmaceuticals International plc logo

CHIEF ACCOUNTING OFFICER Megna Michael R exercised 39,435 units of Class A Ordinary Share at a strike of $11.59 and sold $1,962,781 worth of Class A Ordinary Share (50,490 units at $38.87), decreasing direct ownership by 29% to 27,046 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KNSA (Kiniksa Pharmaceuticals International plc) and more on Quantisnow.